ALS-8112
CAS: 1445379-92-9
Ref. 3D-VHC37992
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
ALS-8112 is a novel antiviral drug that is being developed for the treatment of human immunodeficiency virus (HIV) and hepatitis B virus. The drug has been shown to inhibit syncytial viral infection in primary cells and also inhibits the production of hepatitis B surface antigen. ALS-8112 is an analog of a natural product, L-leucine. The compound inhibits the replication of viruses by binding to their surface glycoproteins, preventing them from attaching to host cells. Molecular modeling studies indicate that ALS-8112 binds to the receptor binding domain of HIV's glycoprotein gp120 and prevents it from interacting with CD4 receptors on host cells.
Chemical properties
Technical inquiry about: 3D-VHC37992 ALS-8112
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
